Journal of Society of Preventive Korean Medicine (대한예방한의학회지)

Society of Preventive Korean Medicine (대한예방한의학회)
권호 표지

Diagnosis, Treatment and Prevention of Subcortical Vascular Dementia with a Case Report

피질하 혈관성치매의 진단, 치료 및 예방 : 1례 보고와 함께

  • Choi, Seong-Hun (Department of Anatomy and Histology, College of Oriental Medicine, Daeggu Haany University) ;
  • Ku, Sae-Kwang (Department of Anatomy and Histology, College of Oriental Medicine, Daeggu Haany University) ;
  • Cheon, Woo-Hyun (Department of Neurology, College of Oriental Medicine, Daeggu Haany University) ;
  • Baek, Kyung-Min (Department of internal medicine, College of Oriental Medicine, Daeggu Haany University) ;
  • Han, Chang-Hyun (TKM Information Research Division, Korea Institute of Oriental Medicine) ;
  • Kyung, Jeon-Won (Center for Herbal Medicine Improvement Research, Korea Institute of Oriental Medicine) ;
  • Lee, Young-Joon (Department of Preventive Medicine, College of Oriental Medicine, Daeggu Haany University)
  • 최성훈 (대구한의대학교 한의과대학 해부학교실) ;
  • 구세광 (대구한의대학교 한의과대학 해부학교실) ;
  • 전우현 (대구한의대학교 한의과대학 신경과) ;
  • 백경민 (대구한의대학교 한의과대학 심계내과) ;
  • 한창현 (한국한의학연구원 문헌연구센터) ;
  • 전원경 (한국한의학연구원 신한방제제연구센터) ;
  • 이영준 (대구한의대학교 한의과대학 예방의학교실)
  • Received : 2010.10.24
  • Accepted : 2010.12.26
  • Published : 2010.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Vascular dementia(VaD) is currently considered to be the second most common type of dementia. VaD is not a single diagnostic entity, but a heterogeneous syndrome which encompasses several clinicopathological forms of dementia resulting from cerebrovascular diseases. A common form of VaD is subcortical VaD which is characterized by lacunar infarcts and deep white matter changes, leading to a progressive decline in memory and cognitive function. The neuropsychological and cognitive profiles of subcortical VaD have been reported relatively homogeneous. At present, subcortical vascular dementia is regarded as the most important subtype of VaD with getting the attention of vascular dementia. The aims of this study are to discuss the concept of subcortical VaD and its importance focusing on diagnosis, prevention and treatment with a case report.

Keywords

References

  1. 조맹제 외. 치매 노인 유병률 조사. 보건복지가족부. 2008.
  2. Geldmacher DS, Whitehouse PJ. Evaluation of dementia. N Engl J Med. 1996 ; 335(5) : 330-6. https://doi.org/10.1056/NEJM199608013350507
  3. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, et al. Vascular dementia : diagnostic criteria for research studies : report of the NINDS-AIREN international workshop. Neurology. 1993 ; 43 : 250-2. https://doi.org/10.1212/WNL.43.2.250
  4. 대한치매학회. 치매 임상적 접근. 서울 ; 아카데미아. 2006 : 347-447.
  5. de la Torr JC. Vascular risk factor detection and control may prevent Alzheimer's diseas. Ageing Research Review. 2010 ; 9 : 218-225. https://doi.org/10.1016/j.arr.2010.04.002
  6. Chiu HC. Dementia due to subcortical ischemic vascular disease. Clin Cornerstone 2001 ; 3(4) : 40-51. https://doi.org/10.1016/S1098-3597(01)90047-X
  7. Chiu HC. Vascular dementia, a new beginning : shifting focus from clinical phenotype to ischemic brain injury. Neurol Clin. 2000 ; 18 : 951-78. https://doi.org/10.1016/S0733-8619(05)70234-6
  8. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol 2002 ; 1 : 426-36. https://doi.org/10.1016/S1474-4422(02)00190-4
  9. 안탁원, 홍석, 김희철. 뇌혈관성치매에 대한 동서의학적 고찰. 한국한의학연구원논문집. 1996 ; 2(1) : 40-70.
  10. 현경철, 김종우, 황의완. Vascular Dementia에 관한 한의학적 임상연구. 동의신경정신과학회지. 1999 ; 10(1) : 147-157.
  11. Roman GC. Vascular dementia : distinguishing characteristics, treatment and prevention. J Am Geriatr Soc. 2003 ; 51 : 296-304. https://doi.org/10.1046/j.1532-5415.5155.x
  12. Erkinjuntti T, Inzitari D, Pantoni L, Wallin A, Scheltens P, Rockwood K, Roman GC, Chui H, Desmond DW. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl. 2000 ; 59 : 23-30.
  13. Bowler JV. Vascular cognitive impairment. J Neurol Neurosurg Psychiatry 2005 ; 76 (Suppl V) : v35-.v44. https://doi.org/10.1136/jnnp.2005.082313
  14. 이재홍. 혈관성치매의 치료. 대한신경과학회지. 2003 ; 21 : 445-454.
  15. Orgogozo JM, Rigaud AS, Stoffler A, Mobius HJ, Forette F. Efficacy and safety of memantine in patients with mild to moderate vascular dementia : a randomized, placebo-controlled trial (MMM 300). Stroke. 2002 ; 33 : 1834-1839. https://doi.org/10.1161/01.STR.0000020094.08790.49
  16. Rogers SL, Doody RS, Pratt RD Ieni JR. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease : final analysisof a US multicentre openlabel study. Eur. Neuropsychopharmacol. 2000 ; 10 : 195-203.
  17. Pratt RD, Perdomo CA. Results of clinical studies with donepezil in vascular dementia. Am J Geriatr Psychiatry 2002 ; 10(Suppl.1) : 88-89.
  18. Black S, Roman GC, Geldmacher D et al. Efficacy and tolerability of donepezil in vascular dementia : Positive results of a 24- week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke 2003 ; 34 : 2323-2330. https://doi.org/10.1161/01.STR.0000091396.95360.E1
  19. Moretti R, Torre P, Antonello RM et al. Rivastigmine in subcortical vascular dementia : An open 22-month study. J Neurol Sci 2002 ; 203-204 : 141-146. https://doi.org/10.1016/S0022-510X(02)00280-0
  20. Santos MD, Alkondon M, Pereira EF et al. The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system. Mol Pharmacol. 2002 ; 61 : 1222-1234. https://doi.org/10.1124/mol.61.5.1222
  21. Erkinjuntti T, Kurz A, Gauthier S et al. Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease : A randomised trial. Lancet 2002 ; 359 : 1283-1290. https://doi.org/10.1016/S0140-6736(02)08267-3
  22. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Fagard R. Prevention of dementia in randomised double-blind placebocontrolled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 1998 ; 352(9137) : 1347-51. https://doi.org/10.1016/S0140-6736(98)03086-4
  23. Kang YW, Na DL, Hahn SH. A validity study on the Korean Mini-Mental State Examination(K-MMSE) in dementia patients. J Korean Neurol Assoc. 1997 ; 15 : 300-307.
  24. Kang Y. Samsung Neuropsychological Screening Battery. In : Current research in dementia. Seoul : The Korean Dementia Association, 1998 ; 99-107.